Stem Holdings, Inc. (NYSE:ZBH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

On April 27, 2017, the Board of Directors of Stem Holdings, Inc.
accepted the resignation of Jim Murphy as a director of the
Company. The Companys Board is not currently planning a
replacement for Mr. Murphy and the Companys Board of Directors
now comprises four (4) members.

Mr. Murphy submitted his resignation to pursue other interests.

Item 9.01 Financial Statements and Exhibits.

(d)Exhibits

None

About Stem Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company’s product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Stem Holdings, Inc. (NYSE:ZBH) Recent Trading Information

Stem Holdings, Inc. (NYSE:ZBH) closed its last trading session up +1.55 at 119.65 with 2,363,715 shares trading hands.